Literature DB >> 15746248

Genomic and functional delineation of dendritic cells and memory T cells derived from grass pollen-allergic patients and healthy individuals.

Malin Lindstedt1, Asa Schiött, Astrid Bengtsson, Kristina Larsson, Magnus Korsgren, Lennart Greiff, Carl A K Borrebaeck.   

Abstract

Dendritic cells (DCIs) possess a potent ability to modulate and activate specific T-cell responses to allergens, which play a pivotal role in allergic inflammation by secreting cytokines and other mediators. However, the molecular mechanisms by which allergen-challenged DCs regulate specific T-cell responses are still not well characterized. This study aims at elucidating the molecular mechanisms underlying the DC-T-cell interaction during an allergic immune response to grass pollen, using a genomic and functional approach. Transcriptional analysis was performed on grass allergen Phleum pratense-stimulated DCs and on autologous memory CD4(+) T cells co-cultured with allergen-challenged DCs from healthy and allergic donors. DCs from the allergic donors were potent inducers of T-cell proliferation and T(h)2 polarization, as demonstrated by high IL-4, IL-5 and IL-13, and low IFN-gamma production. A gradual up-regulation of activation markers on both DCs and T cells was evident during the co-culture period, demonstrating an educational element of the DC-T-cell interaction. The global transcriptional analysis revealed a differential gene regulation in DCs and T cells derived from allergic donors after stimulation with allergen, as compared with the healthy donors. Peripheral memory CD4(+) T cells from healthy and allergic donors also responded differently after stimulation with allergen-loaded DCs with respect to cytokine production, proliferation, surface marker expression and gene transcription. We found up-regulated genes involved in T(h)2 cell biology, such as genes important for homing, adhesion, signaling and transcription, in addition to genes previously not described in the context of allergy. The panel of differentially expressed genes in the allergic group will form the basis for an increased understanding of the molecular mechanisms in allergy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746248     DOI: 10.1093/intimm/dxh220

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  Dendritic cells and the malaria pre-erythrocytic stage.

Authors:  Marjorie Mauduit; Peter See; Kaitian Peng; Laurent Rénia; Florent Ginhoux
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

2.  Comparative analysis of nonaspanin protein sequences and expression studies in zebrafish.

Authors:  Benoist Pruvot; Véronique Laurens; Françoise Salvadori; Eric Solary; Laurent Pichon; Johanna Chluba
Journal:  Immunogenetics       Date:  2010-09-04       Impact factor: 2.846

3.  Epigenetic and transcriptional dysregulation in CD4+ T cells in patients with atopic dermatitis.

Authors:  Amy A Eapen; Sreeja Parameswaran; Carmy Forney; Lee E Edsall; Daniel Miller; Omer Donmez; Katelyn Dunn; Xiaoming Lu; Marissa Granitto; Hope Rowden; Adam Z Magier; Mario Pujato; Xiaoting Chen; Kenneth Kaufman; David I Bernstein; Ashley L Devonshire; Marc E Rothenberg; Matthew T Weirauch; Leah C Kottyan
Journal:  PLoS Genet       Date:  2022-05-16       Impact factor: 6.020

4.  A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests.

Authors:  Henrik Johansson; Malin Lindstedt; Ann-Sofie Albrekt; Carl A K Borrebaeck
Journal:  BMC Genomics       Date:  2011-08-08       Impact factor: 3.969

5.  Evaluating cellular polyfunctionality with a novel polyfunctionality index.

Authors:  Martin Larsen; Delphine Sauce; Laurent Arnaud; Solène Fastenackels; Victor Appay; Guy Gorochov
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

6.  Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency.

Authors:  Ann-Sofie Albrekt; Henrik Johansson; Anna Börje; Carl Borrebaeck; Malin Lindstedt
Journal:  BMC Pharmacol Toxicol       Date:  2014-02-11       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.